News Archive

2009-11-24
More than 400 scientific publications
The use of the Carmeda® Bioactive surface technology continue to increase every year and so are the number of published scientific reports, which features the technology...

2009-10-21
Carmeda celebrates 25 years!
This year Carmeda celebrates its 25th anniversary. From its very beginning in October of 1984, Carmeda’s mission has been to provide the medical device community with high performance blood...

2008-05-08
Heparin from Carmeda is not contaminated
Heparin from Carmeda is not contaminated In response to the Medtronic News Release dated May 7, 2008 regarding a voluntary and precautionary recall of selected products featuring...

2007-07-05
Carmeda Newsletter, July 2007
Summarized latest news about Carmeda® BioActive Surface coated applications and related publications.

2007-04-20
Substantial bioactivity after 855 days of use
A Berlin Heart Ventricular Assist Device (EXCOR) explant showed that approximately 50% of the initial surface heparin bioactivity is retained on the surface after 855 days of use in a patient. Dr...

2006-12-13
New website launched!
Carmeda has today launched its new redesigned website. The new site has been given a new exciting look and the improved structure will make it easier to find the information you want...

2006-11-17
FDA clears GORE PROPATEN Vascular Graft
The U.S. Food & Drug Administration (FDA) has given W. L. Gore & Associates, Inc. (GORE) clearance to market its GORE PROPATEN Vascular Graft for peripheral use, including lower-limb...

2006-11-16
Spire Decathlon™ Gold officially launched
Spire Biomedical introduces an innovative new product at the ASN conference in San Diego November 15 - 19: the Decathlon Gold End-Point™ Bonded heparin coated catheter, which received market...